Researchers at the University of Oxford have developed a "Stroke Cognition Calculator," a new tool designed to estimate a person's chance of having thinking and memory problems six months after a ...
Among dual-eligible beneficiaries hospitalized for stroke, those enrolled in Medicare Advantage plans were more likely to be discharged to lower-quality ...
Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.
The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect ...
Many people refer to a stroke as the brain’s equivalent of a heart attack. A stroke occurs when there’s an interruption or ...
Please provide your email address to receive an email when new articles are posted on . GLP-1 use may improve mortality after nonfatal MI or stroke in patients with diabetes. Uptake in this population ...
In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...
Patients with atrial fibrillation (AF) and a history of breakthrough stroke—an ischemic stroke that occurs despite use of oral anticoagulation—have a heightened risk for subsequent cerebrovascular ...
Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.
In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results